BRIEF published on 04/30/2025 at 07:35, 1 year ago Nicox publie ses résultats financiers pour l'année 2024 Perte Nette Réserves De Trésorerie Résultats Financiers De Nicox Vente De Revenus De VYZULTA Essais NCX 470
PRESS RELEASE published on 04/30/2025 at 07:30, 1 year ago Nicox Provides Full Year 2024 Financial Results Nicox reports €7.9 million revenue for 2024 with exceptional income of €13.7 million from VYZULTA transfer. Cash of €10.5 million and NCX 470 Phase 3 trial results expected in Q3 2025 Financial Results Revenue Nicox NCX 470 VYZULTA
PRESS RELEASE published on 04/30/2025 at 07:30, 1 year ago Nicox : Résultats financiers de l’année 2024 Nicox annonce résultats financiers 2024, incluant CA de 7,9M€, produits exceptionnels de 13,7M€ et trésorerie de 10,5M€. Études cliniques NCX 470 en cours Résultats Financiers Trésorerie Études Cliniques Nicox NCX 470
BRIEF published on 03/19/2025 at 07:35, 1 year 2 months ago Nicox Completes Final Visit for NCX 470 Phase 3b Whistler Glaucoma Trial Glaucoma Nicox Clinical Results NCX 470 Phase 3b Trial
BRIEF published on 03/19/2025 at 07:35, 1 year 2 months ago Nicox a terminé la dernière visite de l'essai de phase 3b NCX 470 sur le glaucome à Whistler Nicox Résultats Cliniques NCX 470 Glaucome Essai De Phase 3b
PRESS RELEASE published on 03/19/2025 at 07:30, 1 year 2 months ago Nicox Announces Last Patient Completes Final Visit in NCX 470 Phase 3b Whistler Glaucoma Trial Nicox completes final patient visits in Phase 3b Whistler Glaucoma Trial for NCX 470, with results expected May 2025. Denali trial in progress, results planned for Q3 2025 Clinical Development Nicox NCX 470 Phase 3b Glaucoma Trial
PRESS RELEASE published on 03/19/2025 at 07:30, 1 year 2 months ago Nicoxannonce que la visite finale du dernier patient a été effectuée dans l’étude de phase 3b Whistler sur le NCX 470 pour le glaucome Nicox annonce la fin de la visite du dernier patient dans l'étude de phase 3b Whistler sur le NCX 470 pour le glaucome. Résultats attendus en mai 2025 Étude Clinique Nicox NCX 470 Glaucome Phase 3b
BRIEF published on 01/28/2025 at 07:35, 1 year 3 months ago Nicox : Participation aux Grands Congrès en 2025 Investissement Ophtalmologie Congrès Nicox NCX 470
BRIEF published on 01/28/2025 at 07:35, 1 year 3 months ago Nicox: Participation in Major Congresses in 2025 Investment Ophthalmology Congress Nicox NCX 470
PRESS RELEASE published on 01/28/2025 at 07:30, 1 year 3 months ago Nicox : Présentation Scientifique et Participation aux Congrès du premier semestre 2025 Nicox annonce sa participation à des congrès internationaux en ophtalmologie et finance au premier semestre 2025, y compris l'AGS 2025 Congrès Annuel Finance Ophtalmologie Congrès Nicox AGS 2025
Published on 05/22/2026 at 08:00, 4 hours 17 minutes ago Caledonia Mining Corporation Plc: Refiling of Bilboes Gold Project Feasibility Study National Instrument 43-101 Technical Report
Published on 05/21/2026 at 23:00, 13 hours 17 minutes ago Silver Wolf Adopts Semi-Annual Financial Reporting
Published on 05/21/2026 at 23:00, 13 hours 17 minutes ago Medicure Reports Financial Results for Quarter Ended March 31, 2026 and Schedules May 25, 2026 Conference Call
Published on 05/21/2026 at 23:00, 13 hours 17 minutes ago Revival Gold Announces Adoption of Shareholder Rights Plan and Corporate Update
Published on 05/22/2026 at 11:33, 44 minutes ago Project WAL reserves capacity on GASCADE’s H2 core network
Published on 05/22/2026 at 11:30, 47 minutes ago AppliedAI and McKinsey & Company collaborate to rapidly rewire regulated enterprise processes with AI
Published on 05/22/2026 at 11:05, 1 hour 12 minutes ago RITFIT Partners with LA Galaxy's Marco Reus, Redefining High Quality Training at Home and Showcasing the Evolution of Professional Home Gym Ecosystems
Published on 05/22/2026 at 11:05, 1 hour 12 minutes ago Hisense Introduces UR8 with Natural and Real Color, Bringing Next-Generation RGB MiniLED Technology to More Homes
Published on 05/22/2026 at 11:00, 1 hour 17 minutes ago EQS-Adhoc: Gothaer All2025 financial year: BarmeniaGothaer reports above-market growth and high profitabilitygemeine Versicherung AG:
Published on 05/22/2026 at 08:30, 3 hours 47 minutes ago Eiffage is building four solar power plants for the NOOR Atlas programme in Morocco
Published on 05/22/2026 at 08:30, 3 hours 47 minutes ago Eiffage réalise quatre centrales photovoltaïques dans le cadre du programme NOOR Atlas au Maroc
Published on 05/21/2026 at 17:45, 18 hours 32 minutes ago CEGEDIM: DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 05/21/2026 at 17:45, 18 hours 32 minutes ago CEGEDIM: DECLARATION D’ACTIONS ET DE DROITS DE VOTE
